An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis. Wang X, Zhang Y, Jin Y, Dai L, et al. Cell 2025;188:4225-4238.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang X, Zhang Y, Jin Y, Dai L, et al. An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis. Cell 2025;188:4225-4238.
PMID: 40562027